Actively Recruiting
Simethicone as Part of ERAS in Bariatric Surgery Patients
Led by Madigan Army Medical Center · Updated on 2025-06-15
260
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
CONDITIONS
Official Title
Simethicone as Part of ERAS in Bariatric Surgery Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for foregut surgical procedures including bariatric surgery, hiatal hernia repair, or gastric surgery
You will not qualify if you...
- Under 18 years of age
- Undergoing non-foregut procedures
- Allergy to simethicone
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Madigan Army Medical Center
Tacoma, Washington, United States, 98431
Actively Recruiting
Research Team
B
Brooklyn Williams, DO
CONTACT
C
Christopher Porta, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here